Choksi Laboratories

Home» Pharmaceutical Analysis» Unknown Peak Identification

CLL Workflow for Unknown Peak Identification

Identification of unknown peaks in is now a regulatory requirement. Any unknown peak(s) eluting in LC chromatograms are required to be identified and reviewed to check whether it is API, Excipient or Process related. CLL’s LC-QTOF workflow can make unknown peak identification a breeze.

CLL Workflow for Unknown Peak Identification

Why is unknown impurity identification useful?

CLL Workflow for Unknown Peak Identification

Unknown Peak Identification Graph

CLL Workflow for Unknown Peak Identification

Advantages of CLL Workflow

  • No MS compatible method
    development needed.
  • CLL will replicate your method on LC using your own sample preparations, mobile phase and column.
  • Saves investigation &
    laboratory time

Information from the CLL’s Standard Unknown Impurity Report?

  • Molecular Chemical Formula
  • Molecular Mass
  • MS and MS2 fragments
  • Probable identification with Structure and stated mass accuracy

Additional Information from CLL’s Advanced Report

  • Product or process related impurity
  • Potential source of impurity determined – placebo, reagents, process carry-over, etc.

Sample Volume Required:

Prepared Blank, Standard and Sample vials (1mL each), Mobile phase (1 – 2 Liters), Placebo (5grams), API (2grams).

Additional information required at time of submission for exact
replication of your method and unknown impurity – Column, Your Chromatogram with unknown peak and API peak marked, Instrument
method, STP and Specification.

Turnaround time: 5 working days; Express 48 hoursservices available.

CLL Workflow for Unknown Peak Identification
Scroll to Top